España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Rescheduling
Cannabis Rescheduling Support 'Spans Democrats, Republicans, Independents': Cresco Labs CEO
'It's The First Step, Not The Final Step': Cannabis Rescheduling Push Gains Broad Support
'No Turning Back Now': Cannabis Rescheduling Gains Momentum, Expert Offers Timeline
'It's The First Step, Not The Final Step': Cannabis Rescheduling Push Gains Broad Support
'No Turning Back Now': Cannabis Rescheduling Gains Momentum, Expert Offers Timeline
Federal Rescheduling: What It Could Mean For Cannabis Banking And Capital Markets
Cannabis Rescheduling Could Reverse 'Decades Of Misguided Drug Policy,' Says Key Industry Organization Following DEA Hearing Rescheduling (UPDATED)
Federal Rescheduling: What It Could Mean For Cannabis Banking And Capital Markets
Cannabis Rescheduling Could Reverse 'Decades Of Misguided Drug Policy,' Says Key Industry Organization Following DEA Hearing Rescheduling (UPDATED)
Cannabis Rescheduling: Will It Change The Industry Or Just Prolong The Wait?
Harris-Walz Could Spark 'Single Largest Catalyst' In Cannabis Industry, Says Expert
Read More...
Rescheduling Recent News
Investor Confidence In Cannabis Is 'Amped Up' As VCs And Private Equity Firms Shift Perception, Expert Says
Investor confidence in cannabis industry rising due to regulatory changes, with growing interest from venture capital and private equity firms. Kevin Hart highlights progress and challenges at Benzinga Cannabis Capital Conference.
As Federal Rescheduling Gains Traction, This Cannabis Entrepreneur Wonders How Banking Factors In
Will Bowden, founder and CEO of Grasshopper Farms, who will speak at the upcoming Benzinga Cannabis Capital Conference in Chicago this October.
Will Federal Policy Changes Finally Free Cannabis Businesses From Tax Burdens?
Beau Whitney, founder and chief economist at Whitney Economics, shares his insights on potential financial benefits and global implications of rescheduling cannabis and enhanced access to banking services, ahead of the Benzinga Cannabis Capital Conference this October.
Federal Cannabis Shift: 'The Industry Is Projected To Surpass $100 Billion By 2030,' Says Expert
Justice Department proposes reclassifying marijuana from Schedule I to III, acknowledging its medical benefits but not legalizing recreational use. Federal involvement may increase regulatory complexity for financial institutions.
EXCLUSIVE: DOJ's Marijuana Rescheduling 'A Game-Changer For Profit Margins And Cash Flow'
The recent reclassification of marijuana by the Justice Department is expected to have a significant impact on the cannabis industry, particularly in New Jersey.
Anti-Cannabis Group Raises Money To Scuttle DEA Rescheduling Effort
Almost immediately following the DEA's announcement, "Smart Approaches to Marijuana" (SAM) began soliciting donations to oppose this change.
US Cannabis Council Calls DEA Historic Decision To Reclassify Cannabis 'A Tectonic Shift'
Conklin emphasized the importance of this decision, stating, "The US Cannabis Council strongly supports the move by the DEA"
DEA's Resistance To Cannabis Rescheduling Ignites Policy Clash
Growing discord between White House and DEA over rescheduling of marijuana. DEA cites unproven medical benefits and potential for abuse, in contrast to HHS findings.
EXCLUSIVE: 'Undo The Harms Of The War On Drugs,' Says Glass House CEO
Kyle Kazan, CEO of Glass House Brands, shares his thoughts on the cannabis industry, Greenhouse 5's impact, DEA rescheduling, and the importance of social justice.
Seattle Physician Launches Push To Reschedule Psilocybin For Medical Use
The DEA recently increased its quota for psilocybin for 2022, as well as for the legal production of psychedelic drugs such as MDMA and DMT, in response to heightened demand and